HepC Micro-elimination on MSM and TGW Population.

Projecte dels NOMS Hispanosida13,161 enrolled

Overview

This is an observational study, in which a single visit will be carried out, which includes a questionnaire on sexual habits and in which the possibility of carrying out a screening for Hepatitis C will be offered. Depending on the score obtained in the questionnaire, the screening will be carried out using a rapid serology test or viral load. During the first year, a SCORE will be developed to classify the risk of positive results. This SCORE will be used during phase 2 to offer users of the centres a targeted screening based on the Pre-test score.

Study Type

OBSERVATIONAL

Enrollment

13,161

Conditions

Hepatitis C PrEP Drugs of Abuse

Eligibility

Sex: MALEMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. All BCN Checkpoint and BCN PreP·Point clients. 2. 18 years and older. 3. HIV uninfected or diagnosticated in the center in the last 7 days prior to the study inclusion. 4. Men that have sex with men or transgender women. 5. Signature of written consent form. 6. Ability to comply with the requirements of the study protocol. Exclusion Criteria: 1. Knowledge of HIV infection from more than 7 days 2. Knowledge of active HCV infection

Locations (1)

BCN checkpoint

Barcelona, Spain

Outcomes

Primary Outcomes

Hepatitis C active infection

Confirmed Hepatitis C active infection

Time frame: August 2021 o September 2023

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.